Form 4 for OKYO OKYO Pharma Ltd
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-19 · accession 0001493152-22-014438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-19 | 2022-05-19 | OKYO | JACOB GARY S | CEO, Dir | P - Purchase | $4.00 | +12.5K | 12.5K | New | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2022-05-19 | P | A | 12,500 | $4.00 | 12,500 | D | — | — |